<DOC>
	<DOCNO>NCT00556075</DOCNO>
	<brief_summary>The purpose study determine whether Proellex safe effective treatment symptomatic endometriosis .</brief_summary>
	<brief_title>Safety Efficacy Study Evaluate Proellex Treatment Premenopausal Women With Symptomatic Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Premenopausal woman age 1848 inclusive Endometriosis document laparoscopic surgical assessment within past ten ( 10 ) year Clinical symptom endometriosis least past three ( 3 ) month Endometriosis symptom Must sexually active unless sexually inactive endometriosisrelated dyspareunia Must regular steady menstrual cycle last 24 36 day detectable ovulation baseline period use ovulation monitor kit ( time endometrial biopsy ) Other inclusion criterion may apply Six ( 6 ) month without menstrual period , Prior hysterectomy Prior bilateral oophorectomy Diagnosis osteopenia Present history condition cause nonendometriosisrelated dyspareunia Presence excessive bleeding menorrhagia Abnormal screen endometrial biopsy Other exclusion criterion may apply</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>Pelvic pain</keyword>
	<keyword>Oral progesterone blocker</keyword>
</DOC>